相关实验视频

Updated: Jan 15, 2026

Pre-Conditioning the Airways of Mice with Bleomycin Increases the Efficiency of Orthotopic Lung Cancer Cell Engraftment

Pre-Conditioning the Airways of Mice with Bleomycin Increases the Efficiency of Orthotopic Lung Cancer Cell Engraftment

Published on: June 28, 2018

肺部疾病的基于细胞的治疗方法:概述和前景

A M van der Does¹, L V Schledorn², R Olmer²

¹PulmoScience Lab, Department of Pulmonology, Leiden University Medical Center, Leiden, the Netherlands.

Advanced drug delivery reviews

|October 13, 2025

概括

再生细胞疗法对慢性肺部疾病 (如COPD) 是有前途的,但临床成功需要更多的研究. 优化细胞类型,输送和安全性对于有效的肺组织修复至关重要.

科学领域:

肺部病理学肺部病理学
再生医学是一种再生医学.
细胞疗法细胞疗法

背景情况:

慢性肺病 (CLD),包括COPD,肺纤维化和高血压,构成了日益严重的全球健康挑战.
这些疾病会导致渐进的肺组织损伤,特别是在气泡中,目前的治疗主要提供症状缓解或减缓进展.
再生细胞疗法为修复和恢复受损的肺组织提供了一个有希望的途径.

研究的目的:

审查再生细胞治疗慢性肺部疾病的潜力.
确定临床翻译的当前挑战和未来研究方向.

主要方法:

对临床前研究和初步临床试验的回顾,用于治疗CLD的再生细胞疗法.
对有关细胞来源,施用方法和安全问题的现有文献进行分析.

主要成果:

临床前和早期临床研究表明,对各种细胞类型 (表皮细胞,肌层细胞,内皮细胞,多能干细胞) 有希望.
将这些策略转化为人类仍然存在重大挑战,包括最佳条件,安全性和细胞局部控制.
目前的成功落后于预期,表明需要进一步调查.

结论:

进一步的研究对于确定再生肺疗法的最佳细胞类型和输送方法至关重要.
解决动物模型翻译,安全性和细胞跟踪方面的挑战对于临床应用至关重要.
开发预测性人类模型将有助于在慢性肺部疾病中成功使用再生细胞疗法的临床应用.

关键词:

细胞疗法是一种细胞疗法.慢性肺病是一种慢性肺病.多能干细胞;多能干细胞;再生再生再生的过程维修维修维修维修组织组织组织组织.

更多相关视频

Acellular and Cellular Lung Model to Study Tumor Metastasis

Acellular and Cellular Lung Model to Study Tumor Metastasis

Published on: August 19, 2018

Generation of Human 3D Lung Tissue Cultures 3D-LTCs for Disease Modeling

Generation of Human 3D Lung Tissue Cultures 3D-LTCs for Disease Modeling

Published on: February 12, 2019

相关概念视频

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

COPD: Pathogenesis and Clinical Features

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...

Chronic Obstructive Pulmonary Disease-V: Management

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.

COPD: Management Using Bronchodilators and Corticosteroids

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...